Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Aztreonam (Primary)
- Indications Cystic fibrosis
- Focus Proof of concept; Therapeutic Use
- Acronyms MOMMI1
- 07 Sep 2016 Status changed from recruiting to completed.
- 05 Jan 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 05 Jan 2015 Treatment period has been changed from 56 days to 28 days, patient number decreased from 40 to 22 and date and time of dosing, dose amount by drug removed from treatment table.